Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/12/2009WO2009117584A3 Anti-inflammatory drug delivery system
11/12/2009WO2009114461A3 Angiotensin (1-7) dosage forms and uses thereof
11/12/2009WO2009112708A3 Novel peptide and cosmetic and/or pharmaceutical composition containing same
11/12/2009WO2009111159A3 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same
11/12/2009WO2009103035A3 Templated open flocs of anisotropic particles for enhanced pulmonary delivery
11/12/2009WO2009093240A3 Erythropoietin and fibronectin compositions for bone regeneration
11/12/2009WO2009081369A3 Method for treating fetal growth disorders
11/12/2009WO2009046377A3 Compositions and methods of stem cell therapy for autism
11/12/2009WO2009044406A4 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof
11/12/2009WO2009043519A3 Use of band 3 protein and pacap-27 as a therapeutic agent
11/12/2009WO2009043454A3 Use of pacap-27 as a therapeutic agent
11/12/2009WO2009039976A3 Use of a peptide as a therapeutic agent
11/12/2009WO2009034119A8 Improved derivatives of amylin
11/12/2009WO2009033757A3 Use of mage-3 antigen (271-279) as a therapeutic agent
11/12/2009WO2009033756A3 Use of oxyntomodulin alone or in combination with melanotropin potentiating factor as a therapeutic agent
11/12/2009WO2009033750A3 Use of phm-27 alone or in combination with leu-enkephalin as a therapeutic agent
11/12/2009WO2009033711A3 Use of glp-1 as a therapeutic agent
11/12/2009WO2009008719A3 Treatment and prevention of inflammatory diseases and autoimmune diseases
11/12/2009WO2008157733A3 Fibrin gel for controlled release of pdgf and uses thereof
11/12/2009US20090282495 Neurotrophic factor manf and uses thereof
11/12/2009US20090281287 IL-17 receptor like molecules and uses thereof
11/12/2009US20090281170 Polynucleotide therapy
11/12/2009US20090281165 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281045 Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
11/12/2009US20090281044 Elastin digest compositions and methods utilizing same
11/12/2009US20090281043 Tumor antigen based on products of the tumor suppressor gene wt1
11/12/2009US20090281042 Compositions and methods using same for the detection of viruses
11/12/2009US20090281041 Antiviral cell-penetrating peptides
11/12/2009US20090281040 Methods For Treating Endoplasmic Reticulum (ER) Stress Disorders
11/12/2009US20090281039 Satiety inducing products and a method of their production
11/12/2009US20090281038 Phylloplanins Inhibition of Microbial Growth on Organic Materials
11/12/2009US20090281037 Method of Reducing Injury to Mammalian Cells
11/12/2009US20090281036 Fusion peptide for inhibiting interaction of neuronal nmda receptor (nmdar) and nmdar interacting proteins
11/12/2009US20090281035 Soluble Heterodimeric Receptors and Uses Thereof
11/12/2009US20090281034 Microencapsulation and sustained release of biologically active polypeptides
11/12/2009US20090281033 Control of radiation injury
11/12/2009US20090281032 Modified CCK peptides
11/12/2009US20090281031 Methods and Compositions Related to Improving Properties of Pharmacological Agents Targeting Nervous System
11/12/2009US20090281030 Genes Associated with Macular Degeneration
11/12/2009US20090281029 Lactoferrin complex and method of producing the same
11/12/2009US20090281028 OSK1 peptide analogs and pharmaceutical compositions
11/12/2009US20090281027 Modified vitamin k-dependent polypeptides
11/12/2009US20090281026 Use of BiP or a Variant, Homologue, Derivative or Fragment Thereof in the Manufacture of a Medicament for the Prevention or Treatment of Bone Loss or Bone Resorption
11/12/2009US20090281025 Inhibition of tumor growth and metastasis by atf2-derived peptides
11/12/2009US20090281024 Compositions Comprising Receptor-Associated Protein (RAP) Variants Specific for CR-Containing Proteins and Uses Thereof
11/12/2009US20090281023 Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
11/12/2009US20090281022 Method for Producing Factor VII Glycoforms
11/12/2009US20090281021 Composition and Method for Treating Iron Deficiency Anemia
11/12/2009US20090281020 Pharmaceutical Compositions Comprising Dextran With A Molecular Weight Of 1.0-100 KDA And Processes For Their Preparation
11/12/2009US20090281019 Compositions and methods for treating atrial fibrillation
11/12/2009US20090280987 Method For Solubilising, Dispersing and Stabilising of Substances, Products Manufactured According To The Method As Well As The Use Thereof
11/12/2009US20090280562 Materials and methods for preparing dimeric growth factors
11/12/2009US20090280555 Enzyme treatment of foodstuffs for celiac sprue
11/12/2009US20090280554 Modified vitamin k-dependent polypeptides
11/12/2009US20090280530 Novel collagen-like protein clac, precursor thereof and genes encoding the same
11/12/2009US20090280508 Methods and Reagents for Preparing and Using Immunological Agents Specific for P-Glycoprotein
11/12/2009US20090280495 tyrosine kinase proteins, inhibitors; kits
11/12/2009US20090280198 Combined effects of nutrients on proliferation of stem cells
11/12/2009US20090280192 Method for treating or preventing alzheimer's disease
11/12/2009US20090280190 Anti-angiogenic peptides from the n-terminus of endostatin
11/12/2009US20090280182 Devices for the treatment of wounds and methods and kits therefor
11/12/2009US20090280170 Compositions of GnRH related compounds and processes of preparation
11/12/2009US20090280169 Compositions of peptides and processes of preparation thereof
11/12/2009US20090280168 Chlamydia polypeptides used to prevent, treat, and diagnose Chlamydia infection; 98 KDa OMP antigen designated CPN100686 RY 54
11/12/2009US20090280165 Compounds that bind alpha5beta1 integrin and methods of use
11/12/2009US20090280164 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
11/12/2009US20090280161 Thin Film Multilocular Structure Made of Collagen, Member for Tissue Regeneration Containing The Same, and Method for Producing The Same
11/12/2009US20090280152 Tropoelastin for Promoting Endothelial Cell Adhesion or Migration
11/12/2009US20090280148 Casein nanoparticle
11/12/2009US20090280142 Methods of diagnosis and treatment of osteoporosis
11/12/2009US20090280141 Streptococcal Genes
11/12/2009US20090280137 Methods, Compositions, and Sequences of ZP-Binding Peptides for Immunocontraception of Dogs and Other Animals
11/12/2009US20090280135 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
11/12/2009US20090280126 biological fragments comprising polypeptides, in a combination with phosphatides, used for for immunization or treatment of ischemic cardiovascular disorders, in humans
11/12/2009US20090280124 Methods for the Diagnosis and Treatment of Preeclampsia
11/12/2009US20090280123 comprising a nucleic acid sequence encoding a KIF18A polypeptide being expressed in mesenchymal stem cells; kinesins capable of binding estrogen receptors
11/12/2009US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/12/2009US20090280113 Target for regulating multiple sclerosis
11/12/2009US20090280110 Cell Model for Alzheimer's Disease Pathology
11/12/2009US20090280109 ILT3 and ILT4-related compositions and methods
11/12/2009US20090280107 Modified vitamin k-dependent polypeptides
11/12/2009US20090280106 Pituitary adenylate cyclase acivating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use
11/12/2009US20090280105 Novel Fungal Enzymes
11/12/2009US20090280104 Compositions and methods for inhibiting shiga toxin and shiga-like toxin
11/12/2009US20090280103 Regulation of muscle repair
11/12/2009US20090280102 Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
11/12/2009US20090280101 Method for conversion of uric acid to allantoin and related enzymes
11/12/2009US20090280100 Preventive or Therapeutic Agent for Inflammatory Ocular-Surface Diseases
11/12/2009US20090280094 Treatment of Ischemic Diseases Using Erythropoietin
11/12/2009US20090280092 G-Protein Coupled Receptor 83 As a Molecular Switch for the Induction of Regulatory (immunosuppressive) T-cells
11/12/2009US20090280087 Interferon AlPha And C-Phycocyanin For The Treatment Of Autoimmune Diseases, Allergy And Cancer
11/12/2009US20090280086 Methods and compositions for treating hepatitis c virus
11/12/2009US20090280085 Long Acting Human Interferon Analogs
11/12/2009US20090280084 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
11/12/2009US20090280083 Compounds for the Treatment of Hepatitis C
11/12/2009US20090280082 Methods for treating autoimmune disorders
11/12/2009US20090280081 JAK/STAT pathway inhibitors and uses thereof
11/12/2009US20090280078 Cosmetic composition to accelerate repair of functional wrinkles
11/12/2009US20090280071 Use of repeat sequence protein polymers in personal care compositions
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 3163